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Abstract
Background: The management of pain by GPs for residents of aged care facilities (ACFs) is very
common.
Aim: To measure the prevalence and assess the management of pain in ACF residents, particularly
those with dementia.
Design & setting: A retrospective review of ACF residents’ medical records was undertaken at five
southern Tasmanian (Australia) ACFs.
Method: Data extracted included results of the most recent assessment of pain and its
management, frequency and treatment of pain incidents in the previous 7 days, demographics, and
medical and medication history. Univariate analysis was used to identify variables associated with
increased frequency of pain episodes.
Results: The final analysis included 477 residents. At least one episode of pain in the preceding 7
days was documented in 25.6% (n = 122) of residents’ notes. Pain episodes were most commonly
managed by analgesics (45.5%), massage (40.7%), and heatpacks (13.8%). Residents with dementia
were not less likely to have pain identified during the past week (14% versus 20%; P = 0.09), but
they were much less likely to have pain identified on their most recent pain assessment (P = 0.03).
Conclusion: GPs should carefully consider the suitability of using ‘as required’ analgesics.
Furthermore, on admission to an ACF, GPs need to ensure a patient’s medical history includes all
pain or potentially pain-causing conditions, to ensure that a resident’s pain assessment is complete.
This is especially necessary for those with dementia, to ensure that staff remain vigilant about the
possibility of the resident experiencing pain.
How this fits in
Pain in nursing home residents is prevalent and potentially suboptimally managed, with 17.5% of res-
idents reporting pain 2 times a week being prescribed only ‘as required’ analgesics. To ensure
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optimal pain management is maintained, clinicians need to ensure that residents’ pain management
is dynamic and adjusted to the current pain experience.
The utilisation of non-pharmacological therapies was common, but further research is required to
determine how these should be used to provide the most benefit.
The identification of pain on the pain assessment form for residents with dementia was lower. It is
imperative that resident’s medication history prior to admission to an ACF includes all pain or poten-
tially pain-causing conditions.
Introduction
The prevalence of pain increases with age,1,2 with >80% of ACF residents experiencing
persistent pain.3 The assessment and management of pain for residents of ACFs is complicated by
many factors including: a lack of clinical trial evidence to support pharmacological and non-pharma-
cological therapies (NPTs);4–6 changes to pain perception;7–9 a reluctance to report pain or take
analgesics;10,11 and an increased likelihood of experiencing adverse events or interactions with
analgesics.4,12,13 Additionally, for residents who cannot communicate effectively, pain assessment
relies on using observation tools or informal observation, which have been found to have variable
accuracy in identifying pain,14,15 often resulting in suboptimal pain management, particularly in
those with dementia.16–18
There are also a number of institutional challenges in Australia, as well as internationally, which
complicate pain management including time pressures (for both nursing staff and GPs); inadequate
consultation space for GPs to review patients; the use of agency nurses reducing continuity of care;
low levels of staff training and pay; communication barriers between nursing staff and GPs; and
insufficient remuneration and time allocated for GPs to manage ACF residents.19–22 There is also a
common practice in Australia of pharmacies providing GPs with lists of prescriptions that are needed
for continued dispensing of residents’ dosage administration aids (known as monitored dosage sys-
tems in the UK),23 rather than normal practice of reviewing the patient when new prescriptions are
required. Due in part to all of these challenges, studies have frequently indicated that pain is often
suboptimally treated in ACFs.24–26
The authors previously reported on pain management in ACFs using information recorded during
formal medication reviews undertaken by pharmacists.27 Reviewing 7309 medication profiles of ACF
residents throughout Australia between 2010–2012 demonstrated that analgesic use was high (91%),
with nearly one-third of residents prescribed regular opioids (29%), but the study was limited in its
ability to ascertain the suitability of the prescribed analgesics, as pain frequency was not available
for the residents. Consequently, the primary aims of the present study were to measure the preva-
lence of pain in Tasmanian ACF residents, assess how pain was managed (including analgesics and
NPTs), and examine resident characteristics associated with increased frequency of pain episodes.
Additionally, due to the previously identified suboptimal management of pain in patients with
dementia, this review will also specifically examine the impact of dementia on documentation and
management of pain.
Method
All ACFs in southern Tasmania, Australia with dementia and non-dementia specific beds were con-
tacted to participate in this study (n = 16). Data collection was undertaken between September–
October 2015; this was undertaken by FV, MW, and SR (research assistant). Only permanent resi-
dents of the ACFs were included in this study, with all short-term respite residents excluded. Medical
records were reviewed, and the data extracted included resident demographics, medical and medi-
cation history, information from their most recent pain assessment (see below), and whether the resi-
dent had reported or been identified as experiencing pain in the past 7 days and, if so, how this was
treated. This was based on notes written by the nursing staff and/or documentation of the use of ‘as
required’ analgesics. ACF staff were interviewed at the time of conducting this review regarding
pain management and assessment, and it was noted that pain was frequently informally reviewed
and residents would be assessed whenever pain was noted or suspected in residents.21
As part of the Australian Aged Care Funding Initiative (ACFI), residents must undergo a regular
assessment of their pain and its management.28 These assessments are carried out by the ACF staff,
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generally a registered nurse, on admission to the ACF and thereafter ideally every 3 months and/
or when there is a change in the health status.29 Information from the resident’s most recent pain
assessment was also collected including the site(s) of pain, the cause(s), and prescribed treatment
modalities.
Each resident who was recorded as taking an opioid regularly had their average daily oral mor-
phine equivalence calculated. For ‘as required’ opioids, the calculation was based on the number of
‘as required’ opioid doses they had received in the preceding 7 days. The Charlson Comorbidity
Index (CCI),30 which estimates 1-year mortality based on comorbidities, was calculated for each resi-
dent to assess level of morbidity burden. This measure was chosen so that comparisons could be
made with the previous study.27
Analysis was performed using SPSS Statistics for Windows (version 20). Univariate analysis was
undertaken using c2 and Mann–Whitney U tests to evaluate differences between those who had a
history of dementia and those who did not. Consent was obtained from each facility manager to
review and record de-identified resident information.
Results
Five of the 16 ACFs approached agreed to participate within the timeframe available for study
implementation. The ACFs reviewed were high care facilities (nursing homes), although one facility
also had some low-dependency beds (residential homes). The median number of beds per facility
included in the analysis was 99 (range 85–171).
Records of 496 residents were reviewed. Eighteen were excluded because they either managed
their medications themselves or because their medication charts were not available, and one resi-
dent was excluded because they died in the preceding week. The final analysis included 477 resi-
dents. The median age was 85.1 years (interquartile range [IQR] 80.1–91.2), the median CCI score
was 2 (IQR 1–3), and 65.3% of the residents were female. The majority of residents (n = 382; 80.1%)
were documented as experiencing pain on their most recent ACFI pain assessment. Table 1 shows
the analgesics prescribed on the medication chart to the residents of the ACFs. Analgesics were pre-
scribed to 91.8% of residents, with paracetamol being the most commonly prescribed analgesic.
Table 2 shows the most common causes of pain and the recommended treatment modalities from
the ACFI pain assessment. Musculoskeletal pain was most frequently noted as a cause of pain in resi-
dents, with analgesics being recommended for 70.6% of the residents, followed by
NPTs, particularly heatpacks (49.7%) and massage (43.2%).
Most (74.4%) residents did not report, or were not observed as, experiencing pain during the pre-
ceding 7 days: 8.4% of residents experienced 1 episode; 8.0% experienced 2 episodes; and 9.2%
experienced 3 episodes of pain. The most common forms of management of painful episodes
were the provision of analgesics (45.5%), massage (40.7%), and heatpacks (13.8%). ‘As required’
only analgesics were prescribed to 17.5% of residents who experienced pain 2 times in the past
week. There was also no difference between the use of ‘as required’ only analgesics in those who
experienced 2 painful episodes with or without dementia (16.7% versus 17.3%; P = 0.94). Table 3
shows the characteristics of the residents with and without dementia. This shows that the documen-
tation of pain-causing conditions, as well as documentation of treatment options on the ACFI form,
are less likely to occur for residents with dementia.
Discussion
Summary
This study adds significantly to the understanding of how pain is managed in ACFs and indicates
that the majority of residents have good pain management. Overall, this study has three key
findings: firstly, that the use of NPTs is common when pain is identified; secondly, that a significant
proportion of residents (both with and without dementia) are receiving potentially suboptimal pain
management, especially in relation to the use of ‘as required’ analgesics; and thirdly, that the docu-
mentation on the ACFI pain assessment identified fewer pain-causing conditions and were less likely
to recommend use of NPTs and analgesics to residents with dementia, potentially indicating a
reduced identification of pain-causing conditions in this population.
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Strengths and limitations
This study has a number of strengths, such as the comprehensive data collection, including all medi-
cations taken in the preceding 7 days as well as the number of documented pain instances. Although
it is unlikely, the authors are unable to be certain that there are not systematic differences between
the ACFs that chose to participate and those that did not. A limitation of this study was the small
geographic location in which the study was conducted, and small number of included ACFs. The
results are comparable to a larger Australian study,27 however, in relation to demographics and anal-
gesic use; thus, the results are likely to be generalisable to the wider Australian ACF population.
Due to differences between Australian and international management, however, the generalisability
to non-Australian ACFs is unknown. The methodology of a cross-sectional retrospective review has a
number of limitations and the potential for bias but, due to the high number of residents who
Table 1. Pain management strategies prescribed to the ACF population (n = 477)
Analgesic n (%)
Any analgesic 438 (91.8)
Regularly dosed analgesic 305 (63.9)
As required analgesics 321 (67.3)
Both as required and regularly dosed analgesics 188 (39.4)
Only as required analgesics 131 (27.5)
Regularly prescribed paracetamol 272 (57.0)
As required paracetamol 212 (44.4)
Oral non-steroidal anti-inflammatories, regularly dosed 16 (3.4)
Oral non-steroidal anti-inflammatories, as required 13 (2.7)
Tricyclic anti-depressant 14 (2.9)
Gabapentinoids 40 (8.4)
Regularly prescribed opioidsa 139 (29.1)
Buprenorphine patch 73 (52.5)
Extended release oxycodone/naloxone 28 (20.1)
Weak opioids (tramadol; paracetamol with codeine) 17 (12.2)
Immediate release oxycodone 11 (7.9)
Extended release oxycodone 8 (5.8)
Extended release morphine 5 (3.6)
Fentanyl patch 5 (3.6)
Morphine in a syringe driver 4 (2.9)
Immediate release morphine liquid 2 (1.4)
Hydromorphone 2 (1.4)
Tapentadol 1 (0.7)
As required opioidsa 169 (35.4)
Immediate release oxycodone 68 (40.2)
Morphine sulphate injection 38 (22.5)
Paracetamol with codeine 36 (21.3)
Morphine liquid 19 (11.2)
Codeine phosphate 12 (7.1)
Tramadol 11 (6.5)
Hydrocodone 4 (2.4)
Extended release oxycodone/naloxone 1 (0.6)
Fentanyl injection 1 (0.6)
aPercentage does not equal 100% because some residents were prescribed more than one regular opioid or ’as required’ opioid.
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experience pain in this population, it is likely that the results are generalisable to the wider ACF
population.
It is possible that this study underestimates the prevalence of pain in ACF residents, as it is likely
that a number of residents experienced discomfort and pain and were repositioned, and these inci-
dents were not documented in the notes. More clinically important persistent or intense pain requir-
ing more active treatment are captured, however. The other factor that was unable to be accounted
for in this study was the effect of regularly provided NPTs, such as massage; it is unclear whether
these were consistently provided to the residents or not, and the impact that these have.
Table 2. Cause of pain and treatment modalities prescribed on ACFI assessment
n (%)
Cause of pain (n = 382)
Musculoskeletal, lower extremities
Back or neck pain
Musculoskeletal, upper extremities
Generalised joint pain
Visceral pain
Neuropathic pain
Post-fracture/osteoporosis pain
Inflammatory joint conditions
Headache/migraine
Cancer-related pain
191 (50.0)
134 (35.1)
112 (29.3)
32 (8.4)
17 (4.5)
15 (3.9)
13 (3.4)
13 (3.4)
11 (2.9)
3 (0.8)
Treatment plan (n = 477)a
Analgesics
Heatpacks
Massage
Repositioning
Rest
Gentle exercise/physiotherapy programme
One-on-one calming
Elasticated garment
Technical equipment, for example TENS
337 (70.6)
237 (49.7)
206 (43.2)
151 (31.7)
117 (24.5)
90 (18.9)
47 (9.9)
12 (2.5)
11 (2.3)
aResidents were often documented as having a pain treatment plan even if there were no documented pain causing condition
Table 3. Baseline demographics and patient characteristics of those with and without dementia
Residents with dementia, n (%)(n = 215) Residents without dementia, n (%)(n = 262) P value
Mean age, years (IQR) 85.7 (79.7–90.6) 87.3 (80.9–91.5) 0.07
Female 80 (48.5) 177 (56.9) 0.26
Mean number of regular medicines (IQR) 7 (5–10) 9 (6–12) <0.01
ACFI pain assessment
ACFI pain-causing condition 163 (75.8) 219 (83.6) 0.03
ACFI analgesics 135 (64.3) 193 (74.2) 0.02
ACFI NPT 152 (70.7) 211 (80.5) 0.01
Medication chart
Any analgesia 199 (92.6) 239 (91.2) 0.60
Regularly prescribed 137 (63.7) 169 (64.5) 0.86
As required only 61 (28.4) 70 (27.7) 0.69
RD paracetamol 121 (56.3) 151 (57.6) 0.77
RD opioid 57 (26.5) 83 (31.7) 0.22
MEQ RD opioid, mg (IQR) 0 (0–6) 0 (0–10) 0.22
Pain experience
2 pain experiences per week 30 (14.0) 52 (19.8) 0.09
IQR = interquartile range. NPT= non-pharmacological therapy. MEQ = morphine equivalence. RD = regularly dosed.
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Comparison with existing literature
Undermanagement of pain in residents with cognitive impairment has been frequently noted in the
literature.17,18,27 Positively, this study did not find a significant difference between the management
of those with and without dementia in relation to overall analgesic use (Table 3), as is supported by
another recent Australian study.15 However, there was a lower rate of documented pain conditions
and prescribing of pharmacological therapies and NPTs as part of a pain management plan on the
ACFI pain assessments of patients with dementia. This may indicate that, although treatment did not
vary, there is still underrecognition and poor documentation of pain in residents with dementia. It is
very important that a resident’s medical history is as complete and up-to-date as possible when
entering ACFs, to ensure that any potential or actual pain-causing condition that these residents
may have is noted, and to reduce the likelihood of missed or underidentified pain.
In addition, for residents with dementia, guidelines recommend by-the-clock dosing6 to help
overcome the poor rates of identification of pain in this population. In this study, the use of regular
and ‘as required’-only analgesics was similar in residents with and without dementia. Because resi-
dents with dementia cannot always express their pain, staff must be alert to the signs of pain. Poten-
tially this alertness could be reduced if residents are ’known’ not to have pain, based on their ACFI
pain assessment. Further research is required to understand why the documentation of pain is sub-
stantially lower than in patients who have dementia, and to develop and test strategies to reduce
this underreporting.
In those residents who experienced pain 2 times in 1 week, there was a high reliance (27.5%) on
‘as required’-only analgesics, in residents both with and without dementia. Moreover, 17.5% of resi-
dents who experienced 2 pain incidences in the past week were only prescribed ‘as required’ anal-
gesics. It is possible that the use of ‘as required’ medication may indicate judicial use of analgesics;
for example, if the pain is sporadic in its presentation and/or mild in intensity, or if prescribers
are trying to limit the exposure to opioids due to concerns regarding side effects in this population.
However, it may be that this is indicative of suboptimal pain management in situations where fre-
quent episodes are a marker of poor pain control and/or regular analgesia has not been considered.
This is an area that requires further research to identify the rationale behind the prescribing of ‘as
required’ analgesics in this population, to ensure that optimal prescribing and management occurs.
Suboptimal pharmacological pain management may be worsened by the common practice of
GPs being provided lists of prescriptions required for dosage administration aids, rather than the
standard practice in the community of being reviewed by a GP when a new prescription is required.
This model of care has the potential to result in a situation where analgesic regimens may not be suf-
ficiently assessed on a regular basis, leaving residents on inadequate or inappropriate analgesic regi-
mens. This is a possible contributing factor to the high use of ‘as required’ medications in those
experiencing 2 pain episodes a week.
As noted previously, the frequency of use of non-pharmacological management strategies has
been poorly documented31 in the literature with most studies reviewing analgesic use alone. This is
despite a number of guidelines recommending the use of NPTs in older people.32,33 This study
found that the use of NPTs in addition to pharmacological interventions was commonly included in
pain management plans, as recommended by best practice guidelines,6,32 though the frequency of
the actual delivery of the various NPTs individually or in combination is not known. However, it is still
unclear how NPTs are best utilised, with trials often being of poor quality, although demonstrating
some benefit.34–36 This is an area that requires further research to ensure that residents are receiving
optimal care and the use of NPT is suitable. Further research as to how best engage residents in
gentle movement exercises is also needed to support the use of NPTs alongside analgesics.
Implications for research and practice
This study has important implications for both research and practice. It has been noted in previous
studies21,37 that the documentation of pain in ACF nursing notes is not complete, but medication
provision must be documented. Thus, potentially, the use of ‘as required’ analgesia beyond a certain
level could be treated as a trigger for reassessment of pain management strategies by ACF staff,
GPs, and pharmacists in a multidisciplinary approach. In cognitively impaired residents, GPs might
need to take particular care to ensure accurate recording of existing pain conditions, and be vigilant
with regards to accurate identification of painful episodes and the need for regular (as opposed to
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‘as required’) analgesia. Further research could investigate the effect of more frequent one-to-one
assessment by the GP, nurse practitioner, pharmacist, or ACF nurses on pain frequency, appropriate-
ness of pain management, functionality, and quality of life.
In addition, the evidence base for NPTs needs to be strengthened. In particular, the effectiveness
of NPTs in ACF residents needs further research to ensure that the way in which residents are man-
aged with NPTs is beneficial and undertaken optimally. In conclusion, a multifaceted approach to
improving pain management in ACFs is needed. To ensure optimal pain management is maintained,
the following steps should be taken: (a) clinicians need to ensure that residents’ pain management is
dynamic and adjusted to the current pain experience; (b) skills need to be improved in ACF staff for
identifying pain in potential at-risk groups especially when ‘as required’-only analgesics are pre-
scribed; and (c) research is needed to generate further evidence to support the use of both NPTs.
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